Quadrant Capital »

Cytek Biosciences shares owned by Quadrant Capital

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $549 99 5.55

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
NVIDIA Corporation (NVDA)
Ishares Core Msci Emkt (IEMG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Target Corporation (TGT)

View all positions for Quadrant Capital

Top funds holding Cytek Biosciences

BlackRock
BlackRock
Vanguard Group
Brown Capital Management
Hillhouse Capital Advisors
State Street Corporation
Geode Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management
Morgan Stanley
Bank of New York Mellon
Connor, Clark & Lunn Investment Management

View all funds holding Cytek Biosciences